No abstract available
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Chemotherapy, Adjuvant
-
Clinical Trials, Phase II as Topic
-
Disease Progression
-
Disease-Free Survival
-
Gastrectomy
-
Humans
-
Neoadjuvant Therapy* / adverse effects
-
Neoadjuvant Therapy* / mortality
-
Stomach Neoplasms / drug therapy*
-
Stomach Neoplasms / mortality
-
Stomach Neoplasms / pathology
-
Time Factors
-
Treatment Outcome